9 METERS BIOPHARMA INC
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch NMTRQ and buy or sell other stocks, ETFs, and their options commission-free!About NMTRQ
9 Meters Biopharma, Inc. is a clinical-stage biopharmaceutical company, which focuses on unmet needs in gastroenterology. Its pipeline includes drug candidates for short bowel syndrome (SBS), celiac disease, and three early-stage candidates for undisclosed rare diseases and/or unmet needs.
CEOBethany L. Sensenig, MBA
CEOBethany L. Sensenig, MBA
Employees10
Employees10
HeadquartersRaleigh, North Carolina
HeadquartersRaleigh, North Carolina
Founded2012
Founded2012
Employees10
Employees10
NMTRQ Key Statistics
Market cap1.45K
Market cap1.45K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume869.20
Average volume869.20
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.0005
52 Week high$0.0005
52 Week low$0.00
52 Week low$0.00
Stock Snapshot
As of today, 9 METERS BIOPHARMA INC(NMTRQ) shares are valued at $0.00. The company's market cap stands at 1.45K.
On 2026-07-25, 9 METERS BIOPHARMA INC(NMTRQ) stock opened at —, reached a high of —, and a low of —.
9 METERS BIOPHARMA INC(NMTRQ) shares are trading with a volume of 0, against a daily average of 869.2.
During the past year, 9 METERS BIOPHARMA INC(NMTRQ) stock moved between $0.00 at its lowest and $0.00 at its peak.
During the past year, 9 METERS BIOPHARMA INC(NMTRQ) stock moved between $0.00 at its lowest and $0.00 at its peak.
People also own
Based on the portfolios of people who own NMTRQ. This list is generated using Robinhood data, and it’s not a recommendation.